VanEck Associates’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3M Buy
931,364
+69,354
+8% +$1.7M 0.02% 411
2025
Q4
$19.5M Buy
862,010
+63,554
+8% +$1.38M 0.02% 397
2025
Q3
$16.1M Sell
798,456
-78,736
-9% -$1.32M 0.01% 406
2025
Q2
$12.5M Sell
877,192
-556,407
-39% -$6.5M 0.01% 424
2025
Q1
$15.1M Buy
1,433,599
+488,621
+52% +$5.53M 0.02% 371
2024
Q4
$11.4M Buy
944,978
+36,239
+4% +$474K 0.01% 430
2024
Q3
$11.4M Sell
908,739
-143,593
-14% -$2M 0.01% 418
2024
Q2
$15.2M Sell
1,052,332
-107,479
-9% -$1.72M 0.02% 328
2024
Q1
$18.9M Sell
1,159,811
-211,228
-15% -$3.3M 0.03% 287
2023
Q4
$20.4M Sell
1,371,039
-249,603
-15% -$2.83M 0.04% 237
2023
Q3
$18.2M Sell
1,620,642
-89,661
-5% -$1.04M 0.04% 253
2023
Q2
$17.2M Buy
1,710,303
+321,238
+23% +$2.98M 0.04% 270
2023
Q1
$13.1M Sell
1,389,065
-268,476
-16% -$3.17M 0.03% 298
2022
Q4
$20.3M Buy
1,657,541
+217,344
+15% +$2.71M 0.05% 239
2022
Q3
$17.9M Sell
1,440,197
-475,506
-25% -$8.31M 0.05% 238
2022
Q2
$37.6M Buy
1,915,703
+541,538
+39% +$12.8M 0.1% 181
2022
Q1
$35.9M Buy
1,374,165
+292,157
+27% +$7.78M 0.07% 198
2021
Q4
$30.7M Buy
1,082,008
+83,607
+8% +$2.6M 0.07% 211
2021
Q3
$31.8M Buy
998,401
+68,435
+7% +$2.3M 0.08% 205
2021
Q2
$32.3M Buy
929,966
+24,052
+3% +$793K 0.08% 205
2021
Q1
$26.7M Buy
905,914
+381,731
+73% +$11.7M 0.07% 200
2020
Q4
$16.1M Sell
524,183
-56,617
-10% -$1.73M 0.05% 230
2020
Q3
$16.2M Sell
580,800
-232,914
-29% -$5.9M 0.05% 205
2020
Q2
$17.5M Buy
813,714
+88,360
+12% +$1.95M 0.06% 193
2020
Q1
$16.2M Buy
725,354
+51,010
+8% +$1.4M 0.08% 161
2019
Q4
$19.9M Buy
674,344
+41,064
+6% +$1.12M 0.08% 175
2019
Q3
$16.8M Sell
633,280
-30,632
-5% -$919K 0.08% 176
2019
Q2
$22.4M Buy
663,912
+469,050
+241% +$15.2M 0.11% 163
2019
Q1
$6.25M Sell
194,862
-12,459
-6% -$383K 0.03% 282
2018
Q4
$6.54M Buy
+207,321
New +$6.79M 0.03% 268

Other funds holding ELAN